盈利能力提升+订单持续增长助力长远发展
R&G PharmaStudies (SZ:301333) Xinda Securities·2024-04-23 07:30| --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...